A dynamic cross section of business, clinical and biotechnical expertise with a proven track record of providing rapid access to breakthrough therapeutics.
Under the leadership of Chairman and Chief Executive Officer, Mr. Jean-Jacques Bienaimé, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of more than 3,000 employees worldwide, we are focused on delivering first-in-class and best-in-class therapeutics to patients with rare genetic diseases.
Leadership Team
-
Jean-Jacques BienaiméChairman and Chief Executive Officer
-
Henry J. FuchsM.D., President, Worldwide Research & Development
-
Jeff AjerExecutive Vice President, Chief Commercial Officer
-
G. Eric DavisExecutive Vice President, General Counsel and Secretary
-
C. Greg GuyerPh.D., Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
-
Brian R. MuellerExecutive Vice President, Chief Financial Officer
-
Philip Lo ScalzoSenior Vice President, Chief Compliance Officer
-
Amy WiremanSenior Vice President, Chief Human Resources Officer
-
Brinda BalakrishnanM.D., Ph.D., Senior Vice President, Chief Business Development Officer
Global Compliance & Ethics
We conduct all aspects of our business in accordance with the highest standards of ethical behaviour.
Learn More Global Compliance & Ethics ⌃